The company will use the funds for a European feasibility study for its transcatheter device and for the launch of a ...

Four complex heart surgeries were done without a single chest cut using TPVR Read ahead to know how this minimally invasive ...

Pacific TMVR market. The sector’s expansion is attributed to rising disease prevalence, technological progress, demand for ...

The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid ...

Transcatheter aortic-valve implantation (TAVI) is increasingly performed in patients with severe, symptomatic aortic-valve stenosis.

RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective ...

The findings highlight the importance of having an EP versed in lead management on the heart valve team, one expert says.

Abbott Laboratories (NYSE:ABT) is one of the top 10 defensive stocks to consider in a volatile market. On July 3, analysts at ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

CroíValve announced today that it received new funding from Horizon Europe’s European Innovation Council (EIC) Accelerator ...

Depending on procedure, the transfemoral, segment dominated the market in 2020, and this trend is expected to continue during ...

Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe asymptomatic aortic stenosis, the first in this patient population ...